Researchers from CEA, Inserm, Paris - Sud and Paris - Descartes Universities, and CNRS have developed an animal model that reproduces
the progression of the human disease.
Not exact matches
Some
of the marketing material highlighted in Lion's cross claim includes: «A2 will improve
human health through the consumption
of a2 dairy milk products», «studies suggest that milk containing only the A2 type
of protein may benefit you and your family if you're concerned with certain allergies, immune function or digestive wellbeing» and «there is significant evidence to suggest that beta casein A1 may be a primary risk factor for heart
disease in adult men and also be involved in the
progression of insulin dependent diabetes in children... Beta casein A1... is the most powerful risk factor ever discovered.»
And researchers have developed a wide range
of sophisticated computer models that simulate
human biology and the
progression of developing
diseases.
«The study results elucidate the molecular mechanisms underlying
disease progression in multiple sclerosis models, providing a basis for future clinical trials to determine safety and efficacy
of these chemical agents in
humans with demyelinating disorders,» says Patrizia Casaccia, MD, PhD, Professor
of Neuroscience, Genetics and Genomic Sciences at Mount Sinai and senior author
of the study.
But recent studies in both
humans and lab mice have suggested that motor neurons in the brain — the upper motor neurons — may be involved in
disease progression, although the extent and significance
of this involvement has remained unknown.
«Inappropriate immune response to commensal bacteria and subsequent pathologic inflammation is a contributing factor to the pathogenesis and
progression of many chronic
human diseases, including inflammatory bowel
disease, HIV / AIDS, viral hepatitis, cancer, cardiovascular
disease, and diabetes,» says Sonnenberg.
«ELITE provides proof
of concept and first direct evidence from
human investigation that timing
of hormone therapy is imperative for success in the prevention
of atherosclerosis
progression, the primary underlying pathway that leads to heart
disease and stroke,» Hodis added.
In recent years, the study
of human biology has been shaken up by discoveries
of how the bacteria that live in the gut, the so - called microbiome, affect metabolism, the immune system, and
disease progression.
This species has been shown to demonstrate a
progression of Lyme
disease most similar to
humans, particularly related to erythema migrans, carditis, arthritis, and neuropathy
of the peripheral and central nervous systems.
The new NIST
human genome RMs increase the ability
of DNA sequencing laboratories to be more confident in their reporting
of true positives, false positives, true negatives and false negatives, and therefore, significantly improve genetic tests used for
disease risk prediction, diagnosis, and
progression tracking.
Researchers at University
of California San Diego School
of Medicine have discovered evidence in mice and
humans that stomach (gastric) acid suppression alters specific gut bacteria in a way that promotes liver injury and
progression of three types
of chronic liver
disease.
To determine the effect
of gastric acid suppression on the
progression of chronic liver
disease, Schnabl's team looked at mouse models that mimic alcoholic liver
disease, NAFLD and NASH in
humans.
«The capability
of this method to separate exosomes without altering their biological or physical characteristics potentially offers new pathways to assess
human health as well as the onset and
progression of diseases,» said Subra Suresh, co-corresponding author
of the paper and president - designate
of Nanyang Technological University Singapore, the 21st Century Professor
of Biomechanics in Medicine at the University
of Pittsburgh Medical School, and former president
of Carnegie Mellon University.
However, Dr. Kissler's group discovered that reducing levels
of the RGS1 protein did not slow the
progression of the
disease in mouse models, suggesting that it may not offer much potential for
human treatment.
Fatal
progression of the
disease in
humans can last up to two years.
These animals naturally develop type 2 diabetes in ways that mimic the
human progression of the
disease.
Our finding
of similarity in clinical
progression between
human patients and Huntington's
disease monkeys suggests monkeys could become a preclinical, large animal model for the development
of new treatments.»
Other Gladstone investigators are working to move JM6 — a new compound we developed to reduce the
progression of both Alzheimer's and Huntington's
diseases — into
human trials.
The lack
of disease progression in ad libitum models
of acute alcohol exposure may actually be relevant to
human exposure.
Inclusion Criteria: • Eastern Cooperative Oncology Group (ECOG) performance status
of 0 or 1 • Have histologically or cytologically confirmed advanced or metastatic non-small cell lung cancer (NSCLC)(Stage IIIb or greater) • Measurable
disease, as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 • Known PD - L1 tumor status as determined by an immunohistochemistry (IHC) assay performed by the central laboratory on tissue obtained at Screening • A woman
of childbearing potential must have a negative highly sensitive serum (beta -
human chorionic gonadotropin [beta - hCG]-RRB- at Screening within 14 days prior to study drug administration Inclusion Criteria for Crossover: • Participants must have been randomized to Arm A
of the study and had radiographic
disease progression according to RECIST 1.1 • Participants must have a mandatory biopsy at the time
of disease progression according to RECIST 1.1 prior to crossing over.
There are unexplained links between
human exposure to aluminium and the incidence,
progression and aetiology
of Alzheimer's
disease.
«Over the past ten years, several research groups, including our own, have shown the importance
of certain immune cell subsets in preventing or exacerbating heart
disease in mice, but we are just beginning to understand how the metabolism and function
of these immune cells change during cardiovascular
disease progression in
humans,» says Hedrick.
Abstract: There are unexplained links between
human exposure to aluminium and the incidence,
progression and aetiology
of Alzheimer's
disease.
Scientists studied the
progression of the
disease using mice and
human stem cells and surmised that a cure for the fatal
disease may be possible.
More recently, his lab started studying the genetic basis
of human brain evolution as well as the signaling pathways underlying synaptic loss during early stages
of Alzheimer's
Disease progression.
Epidemiological surveys in
humans indicate that muscle aging influences the
progression of several age - related
diseases in other tissues.
Researchers are also trying to learn about: - The level
of MM - 121 that remains in the
human body at different time points when MM - 121 is combined with docetaxel or pemetrexed - The relationship between the biomarker, heregulin, and cancer cell growth (
disease progression) in people dosed only with docetaxel or pemetrexed.
Epidemiological surveys in
humans indicate that muscle aging influences the
progression of several age - related
diseases in other tissues... >> MORE
Liquid chromatography - mass spectrometry - based parallel metabolic profiling
of human and mouse serum reveals putative biomarkers with the
progression of nonalcoholic fatty liver
diseases.
4/26/2007 UCSD to Participate in Nationwide Trial to Assess Impact
of Omega - 3 Fatty Acid on the
Progression of Alzheimer's
Disease Nutritionists have long endorsed fish as part
of a heart - healthy diet, and now some studies suggest that omega - 3 fatty acids found in the oil
of certain fish and algae as well as
human breast milk may also benefit the brain by lowering the risk
of Al...
Robert D. Schreiber, Ph.D., an associate director
of CRI's Scientific Advisory Council based at Washington University School
of Medicine in Saint Louis, Missouri, developed a new model
of breast cancer that more closely resembles the
progression of hormone receptor - positive
disease in
humans, overcoming a major obstacle in the study
of breast cancer and the development
of new immune - based therapies for the
disease.
There are currently no
disease - modifying treatments that have been shown to slow the
progression or delay the onset
of HD in
humans; however, several compounds have demonstrated promise in animal models
of HD.1 Robust and sensitive markers
of disease progression are required to assess their efficacy in
humans.
Mitochondrial folate transport by SLC25A32 is yet unstudied for its contribution to oncogenesis, despite knowledge that the slc25a32 gene is amplified in
human cancers (including > 40 %
of breast cancers) and this amplification is associated with accelerated
disease progression and death.
«The chronic exposure to high levels
of ROS is associated with the development and / or
progression of pathophysiological processes, and implicated in an increasing number
of human diseases, such as cardiovascular, metabolic, inflammatory and neurogenerative
diseases, cancer as well as muscle atrophy and the ageing process.»
If you have a pre-existing tumor or
Human Growth Hormone deficiency due to a brain lesion, you should be examined routinely for
progression or recurrence
of the underlying
disease process while receiving
Human Growth Hormone.
In young affected dogs retinal structure, rhodopsin expression and photoreceptor activation is normal;
disease progression is characterized by regions
of initial focal photoreceptor degeneration surrounded by areas
of structurally normal retina, which interestingly is very similar to the phenotypes
of humans with RHO mutations [24].
The best available treatment consisted
of continual doses
of mercury, which slowed the
disease's
progression but was toxic to
humans as well.